Free Trial

Lifecore Biomedical (LFCR) News Today

Lifecore Biomedical logo
$8.28 +0.89 (+12.04%)
Closing price 04:00 PM Eastern
Extended Trading
$8.28 0.00 (-0.06%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LFCR Latest News

Lifecore Biomedical, Inc. stock logo
Deutsche Bank AG Reduces Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR)
Deutsche Bank AG lessened its stake in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 91.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 25,433 shares of the company's stock after selling 290,286 shares during th
Lifecore Biomedical, Inc. stock logo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Sold by BNP Paribas Financial Markets
BNP Paribas Financial Markets lessened its stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 72.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,966 shares of the company's stock aft
Lifecore Biomedical, Inc. stock logo
Insider Selling: Lifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Sells 96,137 Shares of Stock
Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) major shareholder Aron R. English sold 96,137 shares of the company's stock in a transaction on Friday, May 23rd. The shares were sold at an average price of $6.75, for a total value of $648,924.75. Following the completion of the sale, the insider now owns 1,554,103 shares in the company, valued at $10,490,195.25. This represents a 5.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.
Lifecore Biomedical, Inc. stock logo
Aron R. English Sells 150,419 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock
Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) major shareholder Aron R. English sold 150,419 shares of the company's stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $7.12, for a total transaction of $1,070,983.28. Following the completion of the transaction, the insider now owns 264,180 shares in the company, valued at approximately $1,880,961.60. This trade represents a 36.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.
Lifecore Biomedical, Inc. stock logo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Aron R. English Sells 1,139,504 Shares
Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) major shareholder Aron R. English sold 1,139,504 shares of the firm's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $6.50, for a total value of $7,406,776.00. Following the completion of the sale, the insider now directly owns 414,599 shares in the company, valued at $2,694,893.50. This trade represents a 73.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.
Lifecore Biomedical, Inc. stock logo
Q4 Earnings Estimate for LFCR Issued By William Blair
Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Equities researchers at William Blair issued their Q4 2025 earnings estimates for Lifecore Biomedical in a research note issued to investors on Wednesday, May 21st. William Blair analyst M. Smock anticipates that the company will earn $0.04
Lifecore Biomedical, Inc. stock logo
William Blair Initiates Coverage on Lifecore Biomedical (NASDAQ:LFCR)
William Blair initiated coverage on Lifecore Biomedical in a report on Wednesday. They set an "outperform" rating on the stock.
Lifecore Biomedical, Inc. stock logo
Insider Selling: Lifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Sells 45,698 Shares of Stock
Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) major shareholder Aron R. English sold 45,698 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $7.03, for a total transaction of $321,256.94. Following the sale, the insider now directly owns 1,662,574 shares of the company's stock, valued at $11,687,895.22. This represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Major shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.
Lifecore Biomedical, Inc. stock logo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock Position Lifted by Legion Partners Asset Management LLC
Legion Partners Asset Management LLC raised its stake in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 49.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,431,823 shares of the com
Lifecore Biomedical, Inc. stock logo
325 Capital LLC Grows Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR)
325 Capital LLC boosted its position in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 57.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,162,466 shares of the company's stock after acquiring
Lifecore Biomedical, Inc. stock logo
Boothbay Fund Management LLC Has $647,000 Holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR)
Boothbay Fund Management LLC trimmed its position in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 53.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 87,142 shares of the company's stock after s
Lifecore Biomedical, Inc. stock logo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Sold by Marshall Wace LLP
Marshall Wace LLP decreased its stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 33.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 133,191 shares of the company's stock after selling 67,509 shares during t
Lifecore Biomedical, Inc. stock logo
Invesco Ltd. Purchases Shares of 555,607 Lifecore Biomedical, Inc. (NASDAQ:LFCR)
Invesco Ltd. acquired a new position in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 555,607 shares of the company's stock, valued at approximately $4,128,000. Inves
Lifecore Biomedical, Inc. stock logo
Geode Capital Management LLC Raises Stock Holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR)
Geode Capital Management LLC grew its holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 14.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 685,746 shares of the company's stock
Lifecore Biomedical, Inc. stock logo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Acquired by Greenhaven Road Investment Management L.P.
Greenhaven Road Investment Management L.P. boosted its stake in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 62.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,616,146 sh
Lifecore Biomedical, Inc. stock logo
116,538 Shares in Lifecore Biomedical, Inc. (NASDAQ:LFCR) Acquired by Alpha Wave Global LP
Alpha Wave Global LP bought a new stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 116,538 shares of the company's stock, valued at approximately $866,00
Lifecore appoints Salus as chief legal, administration officer
Lifecore Biomedical, Inc. stock logo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock Position Decreased by Wittenberg Investment Management Inc.
Wittenberg Investment Management Inc. lowered its holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 80.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,223 shares of the company's stock aft
Lifecore Biomedical, Inc. stock logo
Lifecore Biomedical (NASDAQ:LFCR) Announces Earnings Results, Misses Estimates By $0.05 EPS
Lifecore Biomedical (NASDAQ:LFCR - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.05). Lifecore Biomedical had a negative net margin of 12.52% and a negative return on equity of 315.23%.
Lifecore Biomedical (LFCR) Gets a Hold from Barrington
Lifecore Biomedical, Inc. stock logo
43,700 Shares in Lifecore Biomedical, Inc. (NASDAQ:LFCR) Purchased by Rangeley Capital LLC
Rangeley Capital LLC acquired a new stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 43,700 shares of the company's stock,
Craig-Hallum Keeps Their Buy Rating on Lifecore Biomedical (LFCR)
Lifecore Biomedical, Inc. stock logo
Lifecore Biomedical (LFCR) to Release Earnings on Thursday
Lifecore Biomedical (NASDAQ:LFCR) will be releasing earnings on Thursday, April 3, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=633032)
Get Lifecore Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter.

LFCR Media Mentions By Week

LFCR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LFCR
News Sentiment

0.24

0.62

Average
Medical
News Sentiment

LFCR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LFCR Articles
This Week

2

5

LFCR Articles
Average Week

Get Lifecore Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LFCR) was last updated on 6/24/2025 by MarketBeat.com Staff
From Our Partners